… interferon-α therapy could protect against relapse and improve survival of acute myeloid leukemia patients after allogeneic hematopoietic stem cell transplantation …
MZ Shen, XH Zhang, LP Xu, Y Wang, CH Yan… - Frontiers in …, 2022 - frontiersin.org
… , and a positive result of bone marrow specimen examined by … New molecular markers with
higher sensitivity and specificity … now (59), and future studies can further assess the efficacy of …
higher sensitivity and specificity … now (59), and future studies can further assess the efficacy of …
Interferon-α as maintenance therapy can significantly reduce relapse in patients with favorable-risk acute myeloid leukemia
H Jiang, XH Liu, J Kong, J Wang, JS Jia… - Leukemia & …, 2021 - Taylor & Francis
… bone marrow is referred to in the literature [Citation23]. The method of analysis of bone marrow
… Palva et al. conducted a prospective controlled multicenter trial to determine the value of …
… Palva et al. conducted a prospective controlled multicenter trial to determine the value of …
Preemptive interferon-α treatment could protect against relapse and improve long-term survival of ALL patients after allo-HSCT
S Liu, X Luo, X Zhang, L Xu, Y Wang, C Yan, H Chen… - Scientific Reports, 2020 - nature.com
… was further supported by a large scale study recently 25 . IFN-α can … Our future prospective
studies can further compare the … fresh, and unmanipulated bone marrow cells plus peripheral …
studies can further compare the … fresh, and unmanipulated bone marrow cells plus peripheral …
Azacitidine combined with interferon‐α for pre‐emptive treatment of AML/MDS after allogeneic peripheral blood stem cell transplantation: A prospective phase II study
C Huang, Y Jia, J Yang, Y Cai, Y Tong… - British Journal of …, 2023 - Wiley Online Library
… correlation between DCR in bone marrow and clinical outcomes. … after allogeneic stem cell
transplantation: new methods and … A phase II multicenter study of the addition of Azacitidine to …
transplantation: new methods and … A phase II multicenter study of the addition of Azacitidine to …
Preemptive interferon-α therapy could prevent relapse of acute myeloid leukemia following allogeneic hematopoietic stem cell transplantation: A real-world analysis
S Fan, TZ Pan, LP Dou, YM Zhao, XH Zhang… - Frontiers in …, 2023 - frontiersin.org
… cell transplantation (allo-HSCT). Therefore, this study aimed to further assess its efficacy in
a multicenter … These results should be further confirmed in a prospective study with a larger …
a multicenter … These results should be further confirmed in a prospective study with a larger …
… response of essential thrombocythemia patients treated with pegylated interferon-α: a multi-center study of the German study group-myeloproliferative neoplasms …
F Stegelmann, LL Teichmann, FH Heidel, CC Crodel… - Leukemia, 2023 - nature.com
… (IFN) may also prevent disease progression to SMF, as recently … ET was diagnosed after
bone marrow biopsy in all cases … Prospective studies assessing JAK2 allele burden monitoring …
bone marrow biopsy in all cases … Prospective studies assessing JAK2 allele burden monitoring …
Recombinant interferon-β in the treatment of polycythemia vera and related neoplasms: rationales and perspectives
H Hasselbalch, V Skov, L Kjær, MK Larsen… - Cancers, 2022 - mdpi.com
… are described, and future research directions are outlined for … was not a candidate for bone
marrow transplantation. Thus, … Based on the above data, a multicenter trial of tamoxifen was …
marrow transplantation. Thus, … Based on the above data, a multicenter trial of tamoxifen was …
Type 1 interferon to prevent leukemia relapse after allogeneic transplantation
JM Magenau, D Peltier, M Riwes, A Pawarode… - Blood …, 2021 - ashpublications.org
… Peripheral blood or bone marrow products were selected from the best available matched …
host tissues, similar to experimental studies. Prospective studies have reported GVHD rates of …
host tissues, similar to experimental studies. Prospective studies have reported GVHD rates of …
Haploidentical donor is preferred over matched sibling donor for pre-transplantation MRD positive ALL: a phase 3 genetically randomized study
YJ Chang, Y Wang, LP Xu, XH Zhang, H Chen… - Journal of hematology & …, 2020 - Springer
… To prevent relapse, interferon-α (IFNα) was used as … Further prospective studies investigating
HRQoL are needed to … More multi-center, prospective trials and mechanism studies are …
HRQoL are needed to … More multi-center, prospective trials and mechanism studies are …
Posttransplant cyclophosphamide as GVHD prophylaxis for peripheral blood stem cell HLA-mismatched unrelated donor transplant
MM Al Malki, NC Tsai, J Palmer, S Mokhtari… - Blood …, 2021 - ashpublications.org
… factor, fibroblast growth factor, interferon-α and -γ, interleukin … end point of a multicenter
phase 2 trial of 3 different GVHD … this study and mostly was G1 by Blood and Marrow Transplant …
phase 2 trial of 3 different GVHD … this study and mostly was G1 by Blood and Marrow Transplant …